|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Metformin does not improve survival in patients with hepatocellular carcinoma显示文摘AIM:To assess whether metformin,which has a chemopreventive effect in chronic liver disease,has any chemotherapeutic effect in hepatocellular carcinoma.METHODS:This was a retrospective study of 701 patients with newly diagnosed hepatocellular carcinoma(HCC)seen between January 2005 and June 2011 at Mayo Clinic,Rochester,Minnesota.This patient cohort was a part of the global HCC BRIDGE study,which is a large longitudinal study of HCC determining the realworld experience of HCC characteristics,management and patient outcomes.We defined significant metformin exposure as continuation of this agent at least 90d beyond diagnosis of HCC,and compared survival of diabetic patients on metformin to diabetic patients not on metformin and non-diabetics.RESULTS:Our cohort was 72.9%male,with a mean±SD age of 62.6±12.3 years.The most common etiologies of liver disease were hepatitis C(34%),alcoholic liver disease(29%),fatty liver disease(15%)and hepatitis B(9%).By univariate analysis,using diabetics not on metformin as the reference group,diabetic patients with HCC on metformin had no survival advantage,with a HR(95%CI)of 1.0(0.8-1.3).Non-diabetic HCC patients also did not appear to have a survival advantage as compared to diabetic HCC patients not on metformin,as demonstrated by a HR(95%CI)of1.1(0.7-1.7).Diabetics on metformin beyond 90 d after HCC diagnosis had a longer median survival at 34.2 mo,as compared to 25.5 mo among diabetic patients who were not on metformin or had discontinued metformin within 90 d after HCC diagnosis.This finding was likely due to potential survival bias among those who lived long enough to receive metformin.CONCLUSION:Although the literature suggests a chemotherapeutic effect in other malignancies,our study demonstrates no survival benefit to the use of metformin in diabetic patients with HCC. | Mamatha Bhat Roongruedee Chaiteerakij William S Harmsen Cathy D Schleck Ju Dong Yang Nasra H Giama Terry M Therneau Gregory J Gores Lewis R Roberts | 2014 | World Journal of Gastroenterology2014，20，42： | 11 |
| 2 | 血管紧张素转换酶抑制剂和血管紧张素受体拮抗剂的使用与2019冠状病毒疾病检测阳性之间的关系显示文摘血管紧张素转换酶抑制剂(angiotensin-converting enzyme inhibitor,ACEI)和血管紧张素受体拮抗剂(angiotensin receptor blocker,ARB)在2019新型冠状病毒疾病(coronavirus disease 2019,COVID-19)全球大流行背景下的作用备受争议。此类药物是治疗一些慢性病的必须药物,有建议停止使用这些药物. | Mehta N KalraA Nowacki AS Anjewierden S Han Z Bhat p Rubio AEC Jacob M Procop GW Harrington S Milinovich A Svensson LG Jehi L Young JB Chung MK 周卫(译) 叶鹏(校) | 2020 | 中华高血压杂志2020，28，5： | 9 |
| 3 | The hormone resistin links obesity to diabetes显示文摘 | Steppan CM Bailey ST Bhat S Brown EJ Banerjee RR Wright CM Patel HR Ahima RS Lazar MA | | 0，，： | 6 |
| 4 | Efficacy of pancreatoscopy for pancreatic duct stones:A systematic review and meta-analysis显示文摘BACKGROUND Pancreatic duct stones can lead to significant abdominal pain for patients.Per oral pancreatoscopy(POP)-guided intracorporal lithotripsy is being increasingly used for the management of main pancreatic duct calculi(PDC)in chronic pancreatitis.POP uses two techniques:Electrohydraulic lithotripsy(EHL)and laser lithotripsy(LL).Data on the safety and efficacy are limited for this procedure.We performed a systematic review and meta-analysis with a primary aim to calculate the pooled technical and clinical success rates of POP.The secondary aim was to assess pooled rates of technical success,clinical success for the two individual techniques,and adverse event rates.AIM To perform a systematic review and meta-analysis of POP,EHL and LL for management of PDC in chronic pancreatitis.METHODS We conducted a comprehensive search of multiple electronic databases and conference proceedings including PubMed,EMBASE,Cochrane,Google Scholar and Web of Science databases(from 1999 to October 2019)to identify studies with patient age greater than 17 and any gender that reported on outcomes of POP,EHL and LL.The primary outcome assessed involved the pooled technical success and clinical success rate of POP.The secondary outcome included the pooled technical success and clinical success rate for EHL and LL.We also assessed the pooled rate of adverse events for POP,EHL and LL including a subgroup analysis for the rate of adverse event subtypes for POP:Hemorrhage,post-endoscopic retrograde cholangiopancreatography pancreatitis(PEP),perforation,abdominal pain,fever and infections.Technical success was defined as the rate of clearing pancreatic duct stones and clinical success as the improvement in pain.Randomeffects model was used for analysis.Heterogeneity between study-specific estimates was calculated using the Cochran Q statistical test and I2 statistics.Publication bias was ascertained,qualitatively by visual inspection of funnel plot and quantitatively by the Egger test.RESULTS A total of 16 studies including 383 patients met the inclusion criteria.The technical success rate of POP was 76.4%(95%CI:65.9-84.5;I2=64%)and clinical success rate was 76.8%(95%CI:65.2-85.4;I2=66%).The technical success rate of EHL was 70.3%(95%CI:57.8-80.3;I2=36%)and clinical success rate of EHL was 66.5%(95%CI:55.2-76.2;I2=19%).The technical success rate of LL was 89.3%(95%CI:70.5-96.7;I2=70%)and clinical success rate of LL was 88.2%(95%CI:66.4-96.6;I2=77%).The incidence of pooled adverse events for POP was 14.9%(95%CI:9.2-23.2;I2=49%),for EHL was 11.2%(95%CI:5.9-20.3;I2=15%)and for LL was 13.1%(95%CI:6.3-25.4;I2=31%).Subgroup analysis of adverse events showed rates of PEP at 7%(95%CI:3.5-13.6;I2=38%),fever at 3.7%(95%CI:2-6.9;I2=0),abdominal pain at 4.7%(95%CI:2.7-7.8;I2=0),perforation at 4.3%(95%CI:2.1-8.4;I2=0),hemorrhage at 3.4%(95%CI:1.7-6.6;I2=0)and no mortality.There was evidence of publication bias based on funnel plot analysis and Egger’s test.CONCLUSION Our study highlights the high technical and clinical success rates for POP,EHL and LL.POP-guided lithotripsy could be a viable option for management of chronic pancreatitis with PDC. | Syed M Saghir Harmeet S Mashiana Babu P Mohan Banreet S Dhindsa Amaninder Dhaliwal Saurabh Chandan Neil Bhogal Ishfaq Bhat Shailender Singh Douglas G Adler | 2020 | World Journal of Gastroenterology2020，26，34： | 5 |
| 5 | Diminished lung function, RSV infection, and respiratory morbidity in prematurely born infants 显示文摘 | Broughton S Bhat R Roberts A | 2006 | Arch Dis Child2006，91，1： | 1 |
| 6 | The hormone resistin links obesity to diabetes显示文摘 | Steppan C M Bailey S T Bhat S | 2001 | Nature2001，409，： | 1 |
| 7 | Adhesion of cellulolytic ruminat bacteria to barley straw 显示文摘 | Bhat S Watlace R J Orskov E R | 1990 | Appl Environ Mierobiol1990，56，： | 1 |
| 8 | Heave plate design with computational fluid dynamics 显示文摘 | Holmes S Bhat S Beynet P | 2001 | Journal of Offshore Mechanics and Artic Engineering2001，123，1： | 1 |
| 9 | The hormone resistin links obesity to diabetes显示文摘 | STEPPAN C M BAILEY S T BHAT S | 2001 | Nature2001，409，： | 1 |
| 10 | Precise Point to Point Positioning Control of Flexible Structure显示文摘 | Bhat S P Miu D K | 1990 | ASME J of Dynamic System Measurement and Control1990，112，4： | 1 |
| 11 | The hormone resistin links obesity to diabetes显示文摘 | STEPPAN CM BAILEY ST BHAT S | 2001 | Nature2001，409，18： | 1 |
| 12 | The hormone resistin links obesity to diabetes显示文摘 | Steppen CM Bailey ST Bhat S | 2001 | Nature2001，409，3： | 1 |
| 13 | Output-feedback semiglobal stabilization of stall dynamics for preventing hysteresis and surge in axial-flow compressors显示文摘 | CHATURVEDI N A BHAT S P | 2006 | IEEE Trans Control Syst Technol2006，14，2： | 1 |
| 14 | The hormone resistin links obesity to diabetes 显示文摘 | STEPPAN C M BAILEY S T BHAT S | 2001 | Nature2001，409，： | 1 |
| 15 | The hormone resistin links obe-sity to diabetes显示文摘 | Steppan CM Bailey ST Bhat S | 2001 | Nature2001，409，： | 1 |
| 16 | In-situ technique for synthesizing Fe-TiC composites 显示文摘 | Raghunath C Bhat M S Rohagi P K | 1995 | Scripta Metallurgica Materialia1995，，4： | 1 |
| 17 | The effect of electron and gamma irradiation on the induction of micronuclei in cyto- kinesis -blocked human blood lymphocytes 显示文摘 | Acharya S Sanjeev G Bhat NN | 2009 | Radiat Envi- ron Biophys2009，48，2： | 1 |
| 18 | A new liquid chromatography/mass spectrometry method for 4-(methyl- nitrosamino) -1- (3-pyridyl) -1-butanol (NNAL) in urine 显示文摘 | Bhat S H Gelhaus S L Mesaros C | 2011 | Rapid Communications in Mass Spectrometry2011，25，1： | 1 |
| 19 | Finite-time stability of continuous autonomous systems显示文摘 | Bhat S P Bernstein D S | 2000 | SIAM Journal of Control and Optimization2000，38，8： | 1 |
| 20 | Efficient Prins cyclization in environmentally benign method using ion exchange re- sin catalyst显示文摘 | More G P Rane M Bhat S V | 2012 | Green Chem Lett Rev2012，5，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员